Dr. Christopher M Pace , MD
Urology โข Grapevine, TX
3600 William D Tate Ave Ste 200
Grapevine, TX 76051
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on September 23, 2005; this date does not establish years in practice.
-
Published CMS data list 3,005 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- G2211 โ Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's: 645 service units.
- 81003 โ Automated urinalysis test: 512 service units.
- 99214 โ Established patient outpatient office visit: 496 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 32 records in the table ยท Guide: How to read Medicare Part B data
-
Published CMS data list 2,305 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Finasteride โ 607 prescription fills, including refills.
- Tamsulosin Hcl โ 515 prescription fills, including refills.
- Alfuzosin Hcl Er (Alfuzosin Hcl) โ 214 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 28 records in the table ยท Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 60% of clinicians listed under Urology in Texas (2024, 608 clinicians with data). Median for this group: 1,751. Middle half: 623 to 4,690.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 1,667 in 2020 to 3,005 in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2020โ2024.
Practice Location & Contact Primary Location
3600 William D Tate Ave Ste 200
Grapevine, TX 76051
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Urology Partners Of North Texas, Pllc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
State University Of New York At Buffalo School Of Medicine
1996
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
534 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider, 2024.
Medicare-allowed amount
About $143,494 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
Paid by Medicare
About $107,548 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
30-day fills
4,990 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$350,568 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,076.88 across 37 records.
By nature of payment
- Food and Beverage: $1,076.88 across 37 records.
Reporting-company totals (3 largest of 19)
- Boston Scientific Corporation: $129.06 across 1 record.
- ABBVIE INC.: $106.81 across 4 records.
- Endo USA, Inc.: $89.76 across 4 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
30 years (graduated 1996)
CMS Doctors and Clinicians data list 1996 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2005
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Pace has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Pace as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Grapevine and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 60% of clinicians listed under Urology in Texas (2024, 608 clinicians with data). Median for this group: 1,751. Middle half: 623 to 4,690.
Too few clinicians listed under Urology in Grapevine have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
Close to the middle for clinicians listed under Urology in Texas (2024, 608 clinicians with data). Median for this group: $130,907. Middle half: $56,287 to $242,595.
Too few clinicians listed under Urology in Grapevine have Medicare Part B data for 2024 to compare.
Paid by Medicare
Close to the middle for clinicians listed under Urology in Texas (2024, 608 clinicians with data). Median for this group: $98,400. Middle half: $41,252 to $185,944.
Too few clinicians listed under Urology in Grapevine have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 70% of clinicians listed under Urology in Texas (2024, 667 clinicians with data). Median for this group: 1,254. Middle half: 393 to 2,342.
Too few clinicians listed under Urology in Grapevine have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 70% of clinicians listed under Urology in Texas (2024, 667 clinicians with data). Median for this group: $146,128. Middle half: $29,835 to $354,962.
Too few clinicians listed under Urology in Grapevine have Medicare Part D data for 2024 to compare.
6 active clinicians are listed under Urology with a practice address in Grapevine, TX (961 in Texas).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 80% from 1,667 in 2020 to 3,005 in 2024.
- 2020: 1,667
- 2021: 1,549
- 2022: 1,814
- 2023: 2,100
- 2024: 3,005
-
Medicare-allowed amount
Medicare-allowed amount increased 49% from $96,512 in 2020 to $143,494 in 2024.
- 2020: $96,512
- 2021: $100,678
- 2022: $114,473
- 2023: $122,064
- 2024: $143,494
-
Paid by Medicare
Paid by Medicare increased 37% from $78,606 in 2020 to $107,548 in 2024.
- 2020: $78,606
- 2021: $77,428
- 2022: $88,727
- 2023: $93,033
- 2024: $107,548
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 51% from 1,523 in 2020 to 2,305 in 2024.
- 2020: 1,523
- 2021: 1,750
- 2022: 1,783
- 2023: 2,018
- 2024: 2,305
-
30-day fills
30-day fills increased 60% from 3,113 in 2020 to 4,990 in 2024.
- 2020: 3,113
- 2021: 3,638
- 2022: 3,833
- 2023: 4,337
- 2024: 4,990
-
Part D drug cost
Part D drug cost increased 533% from $55,370 in 2020 to $350,568 in 2024.
- 2020: $55,370
- 2021: $71,915
- 2022: $64,341
- 2023: $96,322
- 2024: $350,568
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $340.51 in 2021 to $1,076.88 in 2025.
- 2021: $340.51
- 2022: $476.10
- 2023: $710.09
- 2024: $777.09
- 2025: $1,076.88
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 โ December 31, 2025): 37 records totaling $1,076.88.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
SpaceOAR VUE System - 10mL | General | $129.06 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $53.23 |
| Ethicon Inc. |
Food and Beverage
In-kind items and services
|
VISTASEAL | General | $40.46 |
| CIVCO Medical Instruments |
Food and Beverage
Cash or cash equivalent
|
โ | General | $35.55 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $34.54 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
KEYTRUDA | General | $34.02 |
| Becton, Dickinson and Company |
Food and Beverage
In-kind items and services
|
โ | General | $33.41 |
| Laborie Medical Technologies Corp. |
Food and Beverage
Cash or cash equivalent
|
Optilume BPH Drug Coated Balloon Catheter | General | $32.46 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $30.00 |
| Cycle Pharmaceuticals Inc |
Food and Beverage
Cash or cash equivalent
|
Venxxiva | General | $29.05 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $29.01 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Nubeqa | General | $28.07 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $27.88 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $27.35 |
| Laborie Medical Technologies Corp. |
Food and Beverage
Cash or cash equivalent
|
Optilume BPH Drug Coated Balloon Catheter | General | $26.67 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Nubeqa | General | $26.59 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $25.90 |
| UROGEN PHARMA, INC. |
Food and Beverage
In-kind items and services
|
JELMYTO | General | $25.88 |
| Ethicon Inc. |
Food and Beverage
In-kind items and services
|
VISTASEAL | General | $25.63 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $24.02 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Nubeqa | General | $23.33 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $23.23 |
| Endo USA, Inc. |
Food and Beverage
In-kind items and services
|
AVEED | General | $23.09 |
| Endo USA, Inc. |
Food and Beverage
In-kind items and services
|
AVEED | General | $22.67 |
| Endo USA, Inc. |
Food and Beverage
In-kind items and services
|
AVEED | General | $22.67 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016โ2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2017โ2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
645 | 426 | $40.10 | $14.84 |
|
81003
Automated urinalysis test
|
512 | 373 | $14.01 | $2.17 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
496 | 343 | $318.00 | $116.94 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
281 | 236 | $27.66 | $10.20 |
|
36415
Insertion of needle into vein for collection of blood sample
|
141 | 106 | $23.12 | $8.59 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
138 | 138 | $413.07 | $151.59 |
|
84153
Psa (prostate specific antigen) measurement, total
|
129 | 98 | $74.85 | $17.76 |
|
87801
Detection test by nucleic acid for multiple organisms, amplified probe(s) technique
|
57 | 19 | $438.75 | $68.80 |
|
84154
Psa (prostate specific antigen) measurement, free
|
45 | 38 | $78.16 | $18.02 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
41 | 38 | $226.54 | $82.92 |
|
87481
Detection test for candida species (yeast), amplified probe technique
|
38 | 19 | $219.31 | $34.39 |
|
87529
Detection test by nucleic acid for herpes simplex virus, amplified probe technique
|
38 | 19 | $219.31 | $34.39 |
|
87798
Detection test by nucleic acid for organism, amplified probe technique
|
38 | 19 | $219.31 | $34.39 |
|
99232
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
|
38 | 27 | $191.60 | $71.20 |
|
99222
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
|
37 | 34 | $317.65 | $117.95 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
34 | 28 | $588.96 | $216.40 |
|
99211
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
|
25 | 21 | $57.76 | $20.71 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
25 | 19 | $448.31 | $166.26 |
|
52332
Insertion of stent in ureter using an endoscope
|
20 | 14 | $1277.39 | $125.43 |
|
81002
Urinalysis, manual test
|
19 | 15 | $19.69 | $3.41 |
|
87496
Detection test by nucleic acid for cytomegalovirus (cmv), amplified probe technique
|
19 | 19 | $219.31 | $34.39 |
|
87500
Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique
|
19 | 19 | $219.31 | $34.39 |
|
87532
Detection test by nucleic acid for herpes virus-6, amplified probe technique
|
19 | 19 | $219.31 | $34.39 |
|
87640
Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique
|
19 | 19 | $219.31 | $34.39 |
|
87651
Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique
|
19 | 19 | $219.31 | $34.39 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Finasteride | Finasteride | 607 | 44,366 | $7,594.67 | 179 |
| Tamsulosin Hcl | Tamsulosin Hcl | 515 | 37,570 | $5,982.52 | 155 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 214 | 16,580 | $4,684.90 | 62 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 199 | 12,640 | $3,411.45 | 57 |
| Solifenacin Succinate | Solifenacin Succinate | 91 | 5,880 | $2,845.28 | 28 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 86 | 3,178 | $661.35 | 35 |
| Gemtesa | Vibegron | 80 | 3,600 | $56,221.45 | 22 |
| Myrbetriq | Mirabegron | 67 | 2,790 | $40,603.15 | 16 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 53 | 204 | $348.09 | 44 |
| Cephalexin | Cephalexin | 50 | 2,797 | $523.95 | 13 |
| Trospium Chloride | Trospium Chloride | 41 | 1,905 | $2,441.88 | 13 |
| Cefdinir | Cefdinir | 31 | 208 | $480.50 | 28 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 30 | 1,417 | $1,075.49 | โ |
| Dutasteride | Dutasteride | 26 | 2,070 | $614.03 | โ |
| Trimethoprim | Trimethoprim | 21 | 1,050 | $912.58 | โ |
| Silodosin | Silodosin | 20 | 840 | $1,176.29 | โ |
| Doxazosin Mesylate | Doxazosin Mesylate | 19 | 1,750 | $480.14 | โ |
| Hydrochlorothiazide | Hydrochlorothiazide | 19 | 1,050 | $67.53 | โ |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 17 | 870 | $1,318.08 | โ |
| Estradiol | Estradiol | 14 | 1,257 | $1,028.75 | โ |
| Terazosin Hcl | Terazosin Hcl | 14 | 1,300 | $158.19 | โ |
| Potassium Citrate Er | Potassium Citrate | 14 | 840 | $903.58 | โ |
| Erleada | Apalutamide | 14 | 420 | $208,847.90 | โ |
| Levofloxacin | Levofloxacin | 13 | 74 | $61.14 | 13 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 13 | 61 | $144.50 | 11 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20080820000578
TX
2961577200
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Urology Partners Of North Texas, Pllc
1901 N Macarthur Blvd, Irving, TX 750612220
Phone: 9725798100
Secondary Practice Locations
3600 William D Tate Ave Ste 200
Grapevine, TX 76051
Phone: 8663678768
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Urology
Doctor of Medicine (M.D.)
Nurse Practitioner - Family
Family Nurse Practitioner (Certified)
Urology
Doctor of Medicine (M.D.)
Radiology - Radiation Oncology
Doctor of Medicine (M.D.)
Urology
Doctor of Medicine (M.D.)
Urology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 3600 WILLIAM D TATE AVE STE 200, GRAPEVINE, TX 76051 (Tel: 8663678768)
Registered at 5001 S COOPER ST STE 201, ARLINGTON, TX 760175993 (Tel: 8663678768)
NPI status registered as active in NPPES database
Registered at 1604 HOSPITAL PKWY, SUITE 202, BEDFORD, TX 760226986 (Tel: 8177848268)
Registered at 1604 HOSPITAL PKWY, SUITE 202, BEDFORD, TX 760226986 (Tel: 8177848268)
Recorded as CHRISTOPHER PACE, MD
Urology (license number reported to NPPES: TX K4762)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Urology Specialists in Grapevine
- Dr. Nathan Graves, MD
- Dr. Bryan Bruner, MD
- Dr. Scott Davidson, MD
- Dr. Patrick Frey, MD
- Dr. Steven Ash, MD
Mailing Address
5001 S Cooper St Ste 201
Arlington, TX 760175993
Phone: 8663678768